• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Respiratory failure following adenosine administration.

作者信息

Burkhart K K

机构信息

Emergency Medical Services, Milton S. Hershey Medical Center, Hershey, PA 17033.

出版信息

Am J Emerg Med. 1993 May;11(3):249-50. doi: 10.1016/0735-6757(93)90138-2.

DOI:10.1016/0735-6757(93)90138-2
PMID:8489671
Abstract

Adenosine is frequently administered to convert the rhythm of patients with paroxysmal supraventricular tachycardia to sinus rhythm. Adverse reactions are common after its administration, but these have been short-lived because adenosine has a half-life of less than 10 seconds. This report describes a 54-year-old male patient with chronic obstructive pulmonary disease who presented with paroxysmal supraventricular tachycardia at 200 beats/min. A 12-mg bolus injection of adenosine aggravated mild bronchospasm and produced respiratory failure. The patient subsequently required ventilatory support for 9 days. The presence of bronchoconstriction should be considered as a possible contraindication to the administration of intravenous adenosine.

摘要

相似文献

1
Respiratory failure following adenosine administration.
Am J Emerg Med. 1993 May;11(3):249-50. doi: 10.1016/0735-6757(93)90138-2.
2
Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.腺苷治疗阵发性室上性心动过速:剂量范围及与维拉帕米的比较。安慰剂对照多中心试验评估。PSVT研究组腺苷研究
Ann Intern Med. 1990 Jul 15;113(2):104-10. doi: 10.7326/0003-4819-113-2-104.
3
Adenosine is worth trying in patients with paroxysmal supraventricular tachycardia on chronic theophylline medication.对于正在接受慢性茶碱治疗的阵发性室上性心动过速患者,腺苷值得一试。
Eur J Med Res. 1998 Aug 18;3(8):380-2.
4
Adenosine-induced cardiopulmonary arrest in a patient with paroxysmal supraventricular tachycardia.
Am J Emerg Med. 2009 Sep;27(7):901.e1-2. doi: 10.1016/j.ajem.2008.11.008.
5
Adenosine-induced non-sustained polymorphic ventricular tachycardia.腺苷诱发的非持续性多形性室性心动过速。
Eur Heart J. 1994 Feb;15(2):281-2. doi: 10.1093/oxfordjournals.eurheartj.a060488.
6
[A randomized, multicenter trial to compare the safety and efficacy of adenosine versus verapamil for termination of paroxysmal supraventricular tachycardia].一项比较腺苷与维拉帕米终止阵发性室上性心动过速的安全性和有效性的随机多中心试验
Zhonghua Nei Ke Za Zhi. 2003 Nov;42(11):773-6.
7
Adenosine for the treatment of paroxysmal supraventricular tachycardia in full-term and preterm newborn infants.腺苷用于治疗足月儿和早产儿阵发性室上性心动过速。
Am J Perinatol. 1996 Aug;13(6):343-6. doi: 10.1055/s-2007-994353.
8
Anaphylactoid reaction to adenosine.对腺苷的类过敏反应。
Prehosp Disaster Med. 1996 Apr-Jun;11(2):144-6. doi: 10.1017/s1049023x00042849.
9
Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist.
J Am Coll Cardiol. 2003 Sep 17;42(6):1098-102. doi: 10.1016/s0735-1097(03)00987-2.
10
Termination of paroxysmal supraventricular tachycardia by intravenous adenosine in a child.静脉注射腺苷终止儿童阵发性室上性心动过速
Anaesthesia. 1989 Apr;44(4):322-3. doi: 10.1111/j.1365-2044.1989.tb11286.x.

引用本文的文献

1
Unmasking Adenosine: The Purinergic Signalling Molecule Critical to Arrhythmia Pathophysiology and Management.揭示腺苷:对心律失常病理生理学及治疗至关重要的嘌呤能信号分子
Arrhythm Electrophysiol Rev. 2020 Feb 12;8(4):240-248. doi: 10.15420/aer.2019.05.
2
Comparative study of the safety of regadenoson between patients with mild/moderate chronic obstructive pulmonary disease and asthma.比较轻度/中度慢性阻塞性肺疾病与哮喘患者使用雷加腺苷安全性的研究。
Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):119-25. doi: 10.1007/s00259-013-2493-9. Epub 2013 Jul 16.
3
Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial.
用于心肌灌注成像的腺苷A2A受体激动剂瑞加诺生在轻度哮喘和中度哮喘患者中的安全性:一项随机、双盲、安慰剂对照试验。
J Nucl Cardiol. 2008 May-Jun;15(3):329-36. doi: 10.1016/j.nuclcard.2008.02.009. Epub 2008 Apr 14.
4
Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial).选择性腺苷A2A激动剂瑞加德松在慢性阻塞性肺疾病患者中的安全性:一项随机、双盲、安慰剂对照试验(RegCOPD试验)。
J Nucl Cardiol. 2008 May-Jun;15(3):319-28. doi: 10.1016/j.nuclcard.2008.02.013. Epub 2008 Apr 14.
5
Respiratory arrest during dipyridamole stress testing.双嘧达莫负荷试验期间的呼吸骤停。
Postgrad Med J. 1997 May;73(859):301-2. doi: 10.1136/pgmj.73.859.301.